Jinhe Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 138 million yuan, an increase of 51.52%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Jinhe Biotechnology released its semi-annual report for 2025, showing an operating income of 1.39 billion yuan, a year-on-year increase of 30.45%. The net profit attributable to shareholders of the listed company was 138 million yuan, a year-on-year increase of 51.52%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 128 million yuan, a year-on-year increase of 50.88%. The basic earnings per share were 0.1787 yuan
According to the Zhitong Finance APP, Jinhe Biotechnology (002688.SZ) released its semi-annual report for 2025, reporting an operating income of 1.39 billion yuan, a year-on-year increase of 30.45%. The net profit attributable to shareholders of the listed company was 138 million yuan, a year-on-year increase of 51.52%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 128 million yuan, a year-on-year increase of 50.88%. The basic earnings per share were 0.1787 yuan